Skip to content
Open access

The STAT1–IRF1–ACSL4 axis drives peritoneal fibrosis and ferroptosis via lipid peroxidation-dependent mechanisms

Oct 2026 · Renal Failure · Vol 48 · 0 citations · 36 references
Medicine

Abstract

Abstract Peritoneal fibrosis, a major complication of long-term peritoneal dialysis, is driven by transforming growth factor-β1 (TGF-β1)-mediated mesothelial cell dysfunction. Emerging evidence links ferroptosis—a lipid peroxidation-dependent cell death—to fibrotic diseases, but the molecular mechanisms in peritoneal pathology remain unclear. Here, we investigate the role of the STAT1–IRF1–ACSL4 axis in TGF-β1-induced fibrosis and ferroptosis in human peritoneal mesothelial cells (HPMCs). HPMCs were stimulated with TGF-β1 to establish an in vitro fibrosis model and subjected to ACSL4 knockdown, ACSL4 overexpression, or ferroptosis inhibition with Ferrostatin-1. TGF-β1 significantly upregulated fibrosis markers (α-SMA, Collagen I), ferroptosis-related proteins (MDA, 4-HNE, PTGS2), and the STAT1–IRF1 signaling pathway, while suppressing the antioxidant system (GPX4, SLC7A11) (P < 0.001). ACSL4 knockdown markedly restored cell viability, reduced lipid peroxidation, Fe2+ accumulation, ferroptosis activation, and inflammatory cytokine secretion (IL-1β, IL-18) (P < 0.001). In contrast, ACSL4 overexpression exacerbated TGF-β1-induced ferroptosis, fibrosis, and inflammation. Mechanistically, ACSL4 regulated activation of the STAT1–IRF1 axis, as evidenced by changes in STAT1 phosphorylation and IRF1 nuclear translocation. Notably, Ferrostatin-1 reversed ACSL4-induced lipid peroxidation, inhibited STAT1–IRF1 activation, restored GPX4 expression, and attenuated fibrotic and inflammatory responses (P < 0.01). Collectively, these findings demonstrate that the STAT1–IRF1–ACSL4 axis integrates lipid peroxidation-dependent ferroptosis with pro-fibrotic and pro-inflammatory signaling in peritoneal mesothelial cells, identifying ACSL4-centered ferroptotic signaling as a potential therapeutic target for peritoneal fibrosis. Clinical trial number Not applicable.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.